BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021;46:3579-95. [PMID: 33825927 DOI: 10.1007/s00261-021-03059-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Inzerillo A, Meloni MF, Taibbi A, Bartolotta TV. Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography. World J Hepatol 2022; 14(5): 911-922 [DOI: 10.4254/wjh.v14.i5.911] [Reference Citation Analysis]
2 Ruan S, Cheng M, Huang H, Hu H, Li W, Xie X, Lu M, Kuang M, Lin M, Wang W. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study. JHC 2022;Volume 9:437-51. [DOI: 10.2147/jhc.s353914] [Reference Citation Analysis]
3 Sheng CZ, Yao GX, Zhang XR, Li D. Correlation between contrast-enhanced ultrasound perfusion parameters and EphB4 expression in hepatocellular carcinoma lesions. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1084-1088 [DOI: 10.11569/wcjd.v29.i18.1084] [Reference Citation Analysis]
4 Zhao D, He N, Shao YQ, Yu XL, Chu J, Yang G. The diagnostic value of contrast-enhanced ultrasound for cervical tuberculous lymphadenitis. Clin Hemorheol Microcirc 2022. [PMID: 35001882 DOI: 10.3233/CH-211355] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Esika S, Mohamed TM, Corinne EWMRR, Philip LM, Andrej LMP, Kevin AMP, Colette MSM, Ji-bin LM, John REP. Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization. Advanced Ultrasound in Diagnosis and Therapy 2021;5:254. [DOI: 10.37015/audt.2021.210018] [Reference Citation Analysis]
6 Hai Y, Savsani E, Chong W, Eisenbrey J, Lyshchik A. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:5162-79. [PMID: 34410432 DOI: 10.1007/s00261-021-03248-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]